PineBridge Investments L.P. raised its position in HealthEquity Inc. (NASDAQ:HQY) by 4.3% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 4,482 shares of the company’s stock after buying an additional 186 shares during the period. PineBridge Investments L.P.’s holdings in HealthEquity were worth $137,000 at the end of the most recent quarter.
A number of other hedge funds have also modified their holdings of the company. Vanguard Group Inc. raised its stake in shares of HealthEquity by 26.3% in the second quarter. Vanguard Group Inc. now owns 3,150,828 shares of the company’s stock worth $95,739,000 after buying an additional 656,849 shares during the last quarter. Principal Financial Group Inc. increased its position in HealthEquity by 3.3% in the second quarter. Principal Financial Group Inc. now owns 258,038 shares of the company’s stock worth $7,840,000 after buying an additional 8,173 shares during the period. Prudential Financial Inc. increased its position in HealthEquity by 6.2% in the second quarter. Prudential Financial Inc. now owns 92,470 shares of the company’s stock worth $2,810,000 after buying an additional 5,410 shares during the period. Teacher Retirement System of Texas increased its position in HealthEquity by 43.9% in the second quarter. Teacher Retirement System of Texas now owns 6,061 shares of the company’s stock worth $184,000 after buying an additional 1,850 shares during the period. Finally, Denver Investment Advisors LLC purchased a new position in HealthEquity during the second quarter worth approximately $203,000. 90.54% of the stock is currently owned by hedge funds and other institutional investors.
Shares of HealthEquity Inc. (NASDAQ:HQY) opened at 37.87 on Tuesday. HealthEquity Inc. has a 12-month low of $15.80 and a 12-month high of $38.10. The stock has a market capitalization of $2.22 billion, a P/E ratio of 97.10 and a beta of 1.61. The firm’s 50-day moving average price is $33.57 and its 200 day moving average price is $28.67.
HealthEquity (NASDAQ:HQY) last issued its earnings results on Tuesday, September 6th. The company reported $0.16 EPS for the quarter, beating analysts’ consensus estimates of $0.13 by $0.03. HealthEquity had a return on equity of 10.89% and a net margin of 15.21%. The firm had revenue of $44.20 million for the quarter. During the same quarter last year, the firm earned $0.08 EPS. The business’s revenue for the quarter was up 44.9% compared to the same quarter last year. Analysts predict that HealthEquity Inc. will post $0.51 EPS for the current fiscal year.
A number of equities analysts have recently commented on HQY shares. SunTrust Banks Inc. restated a “buy” rating on shares of HealthEquity in a report on Thursday, September 8th. Zacks Investment Research upgraded HealthEquity from a “hold” rating to a “buy” rating and set a $39.00 target price on the stock in a report on Thursday, September 8th. Wells Fargo & Co. reiterated a “buy” rating on shares of HealthEquity in a report on Wednesday, June 22nd. TheStreet upgraded HealthEquity from a “sell” rating to a “hold” rating in a report on Tuesday, June 7th. Finally, Robert W. Baird raised their target price on HealthEquity from $31.00 to $35.00 and gave the company a “neutral” rating in a report on Wednesday, September 7th. Three investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company. The stock has a consensus rating of “Buy” and a consensus target price of $36.00.
In other HealthEquity news, CFO Darcy G. Mott sold 10,000 shares of the business’s stock in a transaction dated Monday, August 22nd. The stock was sold at an average price of $29.13, for a total value of $291,300.00. Following the transaction, the chief financial officer now owns 80,000 shares in the company, valued at $2,330,400. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Jon Kessler sold 54,712 shares of the business’s stock in a transaction dated Tuesday, September 20th. The shares were sold at an average price of $35.07, for a total value of $1,918,749.84. Following the completion of the transaction, the chief executive officer now owns 485,288 shares in the company, valued at approximately $17,019,050.16. The disclosure for this sale can be found here. 29.00% of the stock is owned by company insiders.
HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.
Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity Inc. (NASDAQ:HQY).
Receive News & Ratings for HealthEquity Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity Inc. and related companies with MarketBeat.com's FREE daily email newsletter.